Properties (56)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:HealthCorp_Inc.
|
| gptkbp:awards |
Best Workplace 2023
|
| gptkbp:budget |
2022
|
| gptkbp:CEO |
Jane_Smith
|
| gptkbp:clinicalTrials |
gptkb:Asia
gptkb:Australia gptkb:Canada gptkb:USA Europe Yes Phase 1 Phase 2 Phase 3 Phase 3 Trials Phase 4 |
| gptkbp:communityEngagement |
Health Awareness Programs
|
| gptkbp:employees |
500
Paid Time Off Wellness Programs Retirement Plans Stock Options Health_Insurance |
| gptkbp:founded |
1990
|
| gptkbp:founder |
gptkb:John_Reynolds
|
| gptkbp:globalPresence |
Yes
|
| gptkbp:headCoach |
gptkb:Dr._Emily_White
|
| gptkbp:headquarters |
gptkb:New_York,_USA
|
| https://www.w3.org/2000/01/rdf-schema#label |
Reynolds Pharmaceuticals
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:investmentFocus |
Telemedicine Platforms
Health Tech Companies Biotechnology Startups Venture_Capital_Group Digital_Health_Solutions AI_in_Healthcare |
| gptkbp:market |
gptkb:North_America
|
| gptkbp:partnerships |
gptkb:University_of_Medicine
Research Institutions Local Hospitals Non-Profit_Organizations |
| gptkbp:patentCitation |
50+
|
| gptkbp:philanthropy |
Disaster Relief Efforts
Health Education Programs Disease Research Funding Global_Health_Initiatives Community_Health_Initiatives |
| gptkbp:products |
Prescription Drugs
|
| gptkbp:research |
$50 million
|
| gptkbp:research_areas |
Cardiology
|
| gptkbp:researchFocus |
Oncology
|
| gptkbp:revenue |
$200 million
|
| gptkbp:socialMedia |
@ReynoldsPharma
|
| gptkbp:subsidiary |
Reynolds_Biotech
|
| gptkbp:sustainabilityInitiatives |
Green Manufacturing
|
| gptkbp:website |
www.reynoldspharma.com
|